The Corporate Opportunity Doctrine: When a Deal Belongs to the Company

A director hears about a building for sale, a distributor looking for a partner, or a startup raising a round. The company she serves could plausibly want it. She could also buy it herself. The corporate opportunity doctrine decides which of those is allowed, and it decides it after the fact, in a lawsuit brought by people who know how the investment turned out.

The doctrine is part of the duty of loyalty, and it is state law. Delaware's formulation is the most frequently cited, but a company chartered elsewhere may be governed by a materially different test, and an LLC may be governed mostly by its own operating agreement.

The classic test and its four moving parts

Delaware's framework descends from a 1939 decision, Guth v. Loft, and was refined in later cases including Broz v. Cellular Information Systems in 1996. The court asks a group of related questions rather than applying a single rule:

• Line of business. Is the opportunity in a business the company engages in, or one closely related to it and adaptable to its capabilities?
• Interest or expectancy. Did the company have an existing interest in the opportunity, or a reasonable expectancy of acquiring it — a pending negotiation, an option, a strategic plan naming the target?
• Financial ability. Was the company financially able to take the opportunity when it arose? A company that could not have funded it has a weaker claim to it.
• Conflict with duties. By taking the opportunity, would the fiduciary be placed in a position inimical to the duties owed to the company — competing with it, or opposing it in a market?

No single factor decides the case. Delaware courts have described these as guidelines applied to the specific facts, weighed together. That is honest, and it is uncomfortable for anyone who wants to know the answer in advance.

A separate question runs through all of them: how did the fiduciary learn of the opportunity? An offer made to the person in her corporate capacity is close to a settled answer — it belongs to the company. An opportunity discovered through unrelated personal networks, using no company information or resources, is far more defensible. Courts also look at whether company time, staff, data, credit, or relationships were used to develop the opportunity, because those inputs make the resulting deal look like the company's work product.

The tests are not the same everywhere

Because of that spread, the same conduct can be a breach in one state and permissible in another. Do not import a Delaware conclusion into a company chartered in a state that has adopted a mandatory-disclosure approach, and do not assume the state where the business operates supplies the rule — the internal affairs of an entity are generally governed by the law of the state of incorporation or organization.

The safe harbor: present it and get a real answer

The most reliable protection is also the simplest. Formally present the opportunity to the board, disclose the material facts, step out of the discussion, and let disinterested directors decide whether the company wants it. If they decline, the fiduciary is in a substantially stronger position — and in states following a disclosure-first approach, this is not optional.

1. Write it down

   Describe the opportunity in a memo: what it is, how it came to you, the economics, the timeline, and the capital required. An oral mention at the end of a meeting is not a presentation.

2. Disclose the interest

   State clearly that you would take it personally if the company declines, and disclose anyone else involved who has a relationship with the company.

3. Leave the room

   Do not participate in the deliberation or the vote, and do not lobby individual directors beforehand.

4. Let them decide informed

   The board needs enough information to say yes. A presentation engineered to produce a refusal is worse than no presentation, because it converts a close case into a disclosure problem.

5. Record the refusal

   The minutes should recite what was presented, who considered it, why the company declined — capital constraints, strategic fit, risk — and that the declining directors had no interest.

6. Keep the line clean afterward

   Do not use company staff, data, vendors, or credit to pursue the opportunity once it is yours, and do not let the two businesses transact without separate approval.

Verify before relying: a board rejection is powerful, not absolute. It protects only what was disclosed. If the economics presented differ materially from the deal actually taken, the refusal will not cover the difference.

Charter renunciations and contractual waivers

Modern practice does not rely on case-by-case presentations for investors whose whole business is holding overlapping positions. Delaware's General Corporation Law permits a certificate of incorporation — or a board action, in the manner the statute allows — to renounce any interest or expectancy of the corporation in specified business opportunities or specified classes or categories of business opportunities. That provision, found at Section 122(17), is why venture and private equity investors insist on a renunciation clause before taking a board seat: their funds will look at competing companies, and without a waiver every look is a potential claim.

Drafting these clauses well matters more than including them. Points that recur:

• Overbroad renunciation. A waiver covering everything strips the company of protection it may badly want later. Control: define categories by business line, or exclude opportunities offered to the person expressly in a company capacity.
• Asymmetric coverage. Waivers that cover investor designees but not management create a governance imbalance that founders discover during a dispute. Control: decide deliberately who is covered and say so.
• Confidential information leakage. A renunciation waives the opportunity claim, not the duty to protect company information. Control: keep confidentiality obligations expressly intact in the same clause.
• Silence on employees. Charter renunciations typically address directors and officers, not the workforce. Control: handle employees through employment agreements and policies instead.
• Mismatch across documents. The charter says one thing and the investor rights agreement another. Control: reconcile the charter, LLC agreement, side letters, and employment agreements in one pass.

For alternative entities, the Delaware Limited Liability Company Act gives even more room: the operating agreement may expand, restrict, or eliminate fiduciary duties, subject to the implied contractual covenant of good faith and fair dealing. Sponsor-drafted LLC agreements frequently permit members and managers to pursue competing ventures freely. A minority investor in such an entity should read that clause before assuming a default rule protects it.

Leaving, competing, and the timing question

The most litigated fact pattern is not an outright theft. It is a departure. A director or officer decides to leave, and in the weeks before resigning, begins preparing a venture that will pursue something the company might have wanted.

The general principle is that a fiduciary may prepare to compete while still in office — reserving a name, consulting a lawyer, arranging personal financing — but may not compete, solicit the company's customers or employees for the new venture, or take an opportunity that arose while the duty was in force. The line falls between preparation and action, and it is drawn on evidence: dated emails, calendar entries, device forensics, and the sequence of the resignation and the first customer contact.

Resigning does not automatically clean an opportunity that arose earlier. Where the opportunity came to the person because of the corporate position, or was developed with company resources, courts have followed it across the resignation date. The defensible sequence is the reverse: resign first, then pursue, and be able to show that the opportunity arose afterward.

Questions the desk gets

The company could never have afforded the deal. Does that settle it?

It helps and rarely settles it. Financial ability is one factor, and courts have been skeptical of a fiduciary who both declares the company unable to fund a deal and declines to test that by presenting it. The board might have raised capital, brought in a partner, or taken a smaller share. If inability is your defense, the record should show that the board knew about the opportunity and concluded it could not pursue it.

What is the remedy if a fiduciary takes an opportunity that belonged to the company?

Typically the company can seek disgorgement of profits, and courts have imposed a constructive trust so that the asset or venture is held for the company's benefit. Damages measured by the company's loss are also available. Because the remedy tracks the fiduciary's gain, the exposure grows with the success of the deal — a modest investment that becomes very valuable produces a very large claim years later.

Do these rules apply to ordinary employees?

Not in the same form. The doctrine is aimed at directors, officers, and controlling owners. Employees generally owe a duty of loyalty during employment under state law, which limits competing while employed and misusing confidential information, but the opportunity analysis is usually handled by contract instead — employment agreements, confidentiality terms, and any enforceable restrictive covenants, whose validity varies significantly by state.

Can the board approve a director's participation alongside the company?

Yes, and co-investment is common. It is a conflicted transaction, so it runs through the approval architecture rather than the opportunity analysis: disclosure of the material facts, approval by disinterested directors, and terms that do not favor the insider. The mechanics are covered in our brief on related-party transactions. What makes these deals go wrong is usually the allocation of the good part of the deal, not the participation itself.

Does a waiver in the charter protect against every claim?

No. A renunciation removes the corporation's interest in the specified opportunities; it does not waive confidentiality obligations, does not authorize the use of company resources, and does not permit misrepresentation to the board. Claims that would otherwise be framed as opportunity usurpation are frequently re-pleaded as misuse of confidential information or breach of the duty of candor, and a renunciation clause does not answer those.

How to use this brief

If you are a fiduciary looking at a deal, apply a three-question filter before doing anything else. Would a reasonable person say this came to me because of my role? Is it in or near what the company does? Would the company plausibly want it? Two yeses mean you present it. One yes and real doubt still means you present it, because presentation costs a meeting and the alternative costs a lawsuit.

If you sit on the other side — a company, a co-investor, a minority holder — the work is documentary. Confirm what the charter or operating agreement renounces, whether directors' service on other boards was disclosed and approved, and whether the company has a written policy identifying its line of business with enough specificity to be applied. A company that has never defined what it does has a harder time proving that something fell inside it.

Either way, the record decides it. Presentations, refusals, and the reasoning behind them belong in the minutes, kept to the standard described in board minutes and written consents. Expect that record to be requested through the process in books and records demands, and expect scrutiny to intensify if the company is under financial pressure, as described in director duties as insolvency approaches. Where the fiduciary's own protection is at stake, the indemnification package matters, and it is covered in director and officer indemnification. General business-management resources are published by the Small Business Administration, and further governance material sits on the Corporate Operations & Risk desk.

This brief is general information from an independent legal publisher. It is not legal advice and does not evaluate any particular opportunity, waiver, or departure.